How to Understand a Japanese Hair Clinic’s Treatment Menu

Rows of brown and white medicine bottles on white shelves with unreadable labels.

A treatment menu is a good place to start when you compare hair loss clinics in Japan. It should tell you what a clinic offers, how the options differ, and how much the clinic explains before you visit.

Hair loss treatment in Japan is self-pay, which means Japanese public health insurance doesn’t cover it, and you pay the full amount yourself. Because you pay for everything, the menu should help you judge the medical facts, not just package names or promises.

Contents

Start with the four parts of a treatment menu

Organize menu items into four categories: oral medications, topical products, scalp injections (with or without PRP), and diagnostic tests. Then, review the approval status, guidelines, visit frequency, and risks for each category to avoid confusion over brand names.

A quick comparison of the menu groups

Menu groupStatus in JapanWhat to check
Finasteride or dutasterideApproved for male pattern hair lossWhether the clinic explains the daily schedule and six-month review
Topical minoxidilGrade A in the Japanese guidelineHow often it is applied and which skin reactions to expect
Ketoconazole shampooGrade C1: may be usedWhether it is presented as a supporting treatment, not the main one
Injections or PRPGrade C2 for growth factor and cell-based treatments: advised againstWhether the clinic explains the weak evidence and the risks
Oral minoxidilUnapproved for hair lossWhether unapproved status and the risks are clearly stated
TestsDecision tools, not treatmentWhat each test measures and how it changes the plan

Oral medicines: approved options to compare first

Finasteride and dutasteride are the primary oral medications to consider, as they are approved in Japan for treating male pattern hair loss and are commonly available in clinics. Oral minoxidil is distinct, and its related warnings require careful attention.

The 2017 guideline from the Japanese Dermatological Association recommends oral finasteride, oral dutasteride, and topical minoxidil with a grade A, while oral minoxidil is given a grade D recommendation, indicating it should not be used.1

Approved oral treatments should be taken daily, and Japanese package inserts indicate that a doctor typically requires about six months to determine if the medication is effectively slowing hair loss. If you stop the treatment on your own, male pattern hair loss may begin to progress again.

Oral minoxidil may be listed on menus, but it is unapproved for hair loss treatment in Japan. Menus should make this clear, and doctors must explain the risks and identify who should avoid it before prescribing. Unapproved items should not be treated as equivalent to approved medications.

Sorting menu names into the four groups

  • Oral medicines: finasteride, dutasteride, and oral minoxidil, with approval checked separately.
  • Topical products: minoxidil solution or foam and ketoconazole shampoo.
  • Injections and PRP: mesotherapy or platelet-rich plasma delivered into the scalp.
  • Tests: photos, microscope exam, blood work, hair hormone testing, and genetic testing.

Topical minoxidil and ketoconazole shampoo

Topical minoxidil is the primary topical medication recommended in the Japanese guideline and receives a grade A recommendation. Ketoconazole shampoo has weaker support in the guidelines but can be utilized alongside other treatments.

A review of minoxidil indicates that only approximately 1.4% of topical minoxidil is absorbed into the body. A long-term study found that the greatest increase in hair growth occurs in the first year, with smaller improvements observed thereafter.2

A clear menu should say how often to apply a topical, which area to treat, and what skin reactions, such as itching or irritation, may occur where it is applied. If the product combines several ingredients, the menu should tell you what each ingredient is meant to do.

Ketoconazole shampoo is ranked C1 in the Japanese guideline, meaning a doctor may use it, but its guideline support is weaker than for the grade A treatments. If a menu presents it as the core treatment, ask what evidence supports that plan.

Injections and PRP: check the evidence and the plan

Scalp injections and PRP may appear on a menu, but their evidence is weaker than that for the approved medicines.

Mesotherapy means injecting small amounts of substances such as vitamins, peptides, or growth factors into the scalp. PRP means platelet-rich plasma, which is made from your blood and injected back into the scalp.

Methods vary by clinic, including the ingredients, needle depths, activation methods, and number of sessions. The 2017 Japanese guideline places growth factor injections and cell-based treatments in the C2 category, meaning it favors not performing them when the evidence is insufficient.

A network meta-analysis of non-surgical treatments found similar changes in hair count across several main options; however, the authors rated the overall quality of the evidence as low and noted that PRP lacks a standard preparation method.3

PRP needs a close look

A 2025 systematic review found that activated PRP significantly increased hair density compared to placebo. However, the difference in hair thickness was not statistically significant, and results may vary depending on preparation methods.4

If you’re considering PRP treatment, check the number of sessions, the intervals between visits, and any risks like pain, swelling, or bruising. If the information only includes bold promises without addressing risks, keep looking for better options.

Mesotherapy and other scalp injections

A systematic review of injectable therapies revealed mostly small studies with varying methodologies; many side effects were mild, but reports of paradoxical hair loss, scarring, and acute dermatitis were documented.5

The authors also emphasized the need for standardized randomized trials before this type of injection can be considered routine care. A menu should not suggest that an injection is an approved medicine with the same level of support.

Tests on a treatment menu are decision tools

Tests should address a diagnostic question: why is hair thinning and which treatment is safer or more effective for you? A test result cannot determine whether a treatment will be successful.

Photos, microscope exam, and blood work

A clinic may photograph your hair and examine your scalp under a microscope to track changes over time. Blood work can also identify reversible issues, such as low iron levels, before treatment begins.

Genetic and hair hormone tests

Some menus list genetic tests that examine inherited markers associated with male pattern hair loss, as well as hair sample tests for the hormone DHT. While these tests can help a doctor develop a treatment plan, not every clinic offers them, and they cannot guarantee specific outcomes.

If a menu recommends supplements for a deficiency, ask which test finding supports that choice. The evidence for routine supplement use is limited. The recommendation should match a deficiency found in your evaluation.

Turn the treatment menu into a checklist

A well-structured menu lets you compare clinics before your visit, but your final decision should include a conversation with a doctor. Make a note of each item and check whether the menu provides information on approval status, the expected number of visits, and the main risks.

Under Japanese advertising rules for self-pay care, a clinic should clearly explain what the treatment involves, its standard cost, how long it takes and how many sessions it needs, and its main risks or side effects. When those details are missing or hard to find, ask for them directly.

At AGA Medical Care Clinic in Tokyo and Yokohama, our doctors will listen to your concerns and goals during a consultation. Before you decide, you can ask about individual menu items through the contact form.

Frequently asked questions

Do I need to read Japanese to understand a treatment menu?

Not always. Some clinic websites explain their main menu in English, but the Japanese page may contain more detail. Compare the English overview with the Japanese menu, or ask the clinic to confirm an item before you book.

Is oral minoxidil a standard choice if it appears on a menu?

No. In Japan, oral minoxidil is unapproved for hair loss, and the Japanese guideline gives it a grade D recommendation. A doctor should explain that status and the possible risks before prescribing it.

Which menu items have the clearest support for male pattern hair loss?

Finasteride, dutasteride, and topical minoxidil have the clearest guideline support. Each carries a grade A recommendation in the 2017 Japanese guideline for male pattern hair loss.

Should I choose injections or PRP instead of medicine?

Usually not as a first choice, because the Japanese guideline places these treatments in a weaker category and study methods vary. They may be an option after a doctor examines you. Ask why the treatment is being proposed and which evidence applies to your case.

References

1. Manabe, M., Tsuboi, R., Itami, S., Osada, S. I., Amoh, Y., Ito, T., Inui, S., Ueki, R., Ohyama, M., Kurata, S., Kono, T., Saito, N., Sato, A., Shimomura, Y., Nakamura, M., Narusawa, H., Yamazaki, M., & Drafting Committee for the Guidelines for the Diagnosis and Treatment of Male- and Female-Pattern Hair Loss (2018). Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. The Journal of Dermatology, 45(9), 1031-1043. https://doi.org/10.1111/1346-8138.14470

2. Gupta, A. K., Talukder, M., Venkataraman, M., & Bamimore, M. A. (2022). Minoxidil: a comprehensive review. The Journal of Dermatological Treatment, 33(4), 1896-1906. https://doi.org/10.1080/09546634.2021.1945527

3. Gupta, A. K., Mays, R. R., Dotzert, M. S., Versteeg, S. G., Shear, N. H., & Piguet, V. (2018). Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. Journal of the European Academy of Dermatology and Venereology : JEADV, 32(12), 2112-2125. https://doi.org/10.1111/jdv.15081

4. Anitua, E., Tierno, R., & Alkhraisat, M. H. (2025). Platelet-Rich Plasma in the Management of Alopecia: A Systematic Review and Meta-Analysis of Clinical Evidence. Dermatology and therapy, 15(11), 3213-3252. https://doi.org/10.1007/s13555-025-01542-8

5. Beer, J., Boghosian, T., Mendez, H., Sayegh, M., Boghosian, N., & Tosti, A. (2026). Injectable Therapy for Androgenetic Alopecia: A Systematic Review. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 52(7), 659-665. https://doi.org/10.1097/DSS.0000000000004999

Mella, J. M., Perret, M. C., Manzotti, M., Catalano, H. N., & Guyatt, G. (2010). Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Archives of Dermatology, 146(10), 1141-50. https://doi.org/10.1001/archdermatol.2010.256

Ayatollahi, A., Hosseini, H., Gholami, J., Mirminachi, B., Firooz, F., & Firooz, A. (2017). Platelet rich plasma for treatment of non-scarring hair loss: systematic review of literature. The Journal of dermatological treatment, 28(7), 574-581. https://doi.org/10.1080/09546634.2017.1303571

Drake, L., Reyes-Hadsall, S., Martinez, J., Heinrich, C., Huang, K., & Mostaghimi, A. (2023). Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss: A Systematic Review. JAMA Dermatology, 159(1), 79-86. https://doi.org/10.1001/jamadermatol.2022.4867

Share this article
  • URL copied!
  • URL copied!
Contents